Who’s Driving the Bus?
Disruption from new market entrants and issues around price transparency are among the trends that could make life difficult for traditional healthcare stakeholders if they fail to adapt.
Crowdfunding: Assessing Benefits and Risks
Crowdfunding can increase investor participation and engagement between project initiators and potential funders, as well as raise awareness of neglected health issues.
Rebalancing the Portfolio
As they modify their strategies to account for change in 2019, healthcare organizations should consider how risks and rewards might have changed and where they might best redeploy their dollars.
Capital Markets 2018 Wrap-Up and Trends to Consider for 2019
The healthcare sectors’ extended access to abundant, low-cost, and relatively low-risk capital will change in 2019, and tracking four key issues will illuminate how those changes impact capital finance.
Work: The Cure For Political Overload
HFMA President and CEO Joe Fifer discusses why today’s healthcare challenges transcend politics—and the implications for healthcare finance leaders.
Imagining a More Consumer-Centric Approach to Patient Financial Communications
HFMA, the AHA, and AHIP have developed a guide for healthcare consumers designed to help them know how to avoid surprise out-of-network medical bills; healthcare organizations are encouraged to share the guide with their patients.
The 2018 Midterm Elections: Implications for Health Care
The healthcare industry could see some significant changes now that the balance of power in Washington D.C. has shifted.
A Short Guide to Avoiding Unwelcome Surprises
Surprise medical bills are a top concern of American consumers today. HFMA President and CEO Joe Fifer introduces a guide to help consumers avoid these unexpected out-of-network bills.
The 2019 ACA Enrollment Period Begins
Rising premiums and reduced choice among insurance options are two challenges facing health insurance purchasers under the Affordable Care Act in 2019; nonetheless, public support for the act continues to be strong enough to block efforts to repeal the act.
Leading Through an Era of Disruptive Innovation
Many technological and infrastructure investments may seem enticing these days, but healthcare leaders should evaluate which are worthwhile by considering whether they will benefit patients and enhance the value of care.